查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗美容市场（按产品/设备类型、治疗类型、最终用户、性别、分销管道、主要地区）：行业趋势和预测
市场调查报告书
商品编码
1411403

全球医疗美容市场（按产品/设备类型、治疗类型、最终用户、性别、分销管道、主要地区）：行业趋势和预测

Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered, Type of Procedure, End User, Gender, Distribution Channel, and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 294 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2023年，全球医学美容市场价值为350亿美元，在预测期（2023-2035年）复合年增长率为9.3%。

我们认为，近年来对医美解决方案的需求增加是由于多种因素造成的，包括保持年轻外表的愿望、社交媒体的影响、技术进步、名人代言以及美容师和医疗专业人士的支持。你可以COVID-19 大流行也大大促进了每年美容治疗手术数量的增加。根据国际美容整形外科学会（ISAPS）的一项研究，2022年全球将进行超过1500万例侵入性美容手术和1900万例非侵入性美容手术。儘管该行业近90%的客户是女性，但美容医学在男性中也越来越受欢迎。推动男性美容市场成长的趋势与推动女性美容市场成长的趋势相同，包括对自然效果的渴望、微创手术以及对外观意识的提高。

由于这些手术的高需求，医美公司开发了医疗产品和设备。医美公司的主要兴趣在于开发非手术或微创解决方案。最常见的微创治疗包括肉毒桿菌和美容填充剂。这些疗程主要用于改善正常线条和收紧皮肤。然而，美容疗程的好处不仅限于美容；它们还可以帮助解决其他常见的医疗问题。肉毒桿菌用于减少出汗和偏头痛。身体轮廓设备、雷射除毛、去除纹身和指甲治疗是一些常见的非手术治疗方法。塑形仪用于收紧皮肤、减少脂肪、减少脂肪团。

可以在医疗美容诊所和医疗水疗中心接受医疗美容治疗。目前医疗美容市场70%以上由医院、诊所、医疗水疗中心营运。此外，韩国作为世界整容中心，也是人均整容手术数量最多的国家。这要归功于完善的整容手术基础设施和熟练的医疗专业人员，他们鼓励韩国整容医疗旅游。一个主要问题是一些医疗专业人员和医学美容公司违反了监管准则，这可能会导致副作用。透过克服这些挑战并应对日益增长的医美服务需求，医美公司预计将在未来几年实现显着成长。

本报告分析了全球医疗美容市场，并提供了治疗概述、市场的基本结构和最新情况、主要市场促进和限制因素、整体市场规模趋势展望以及按细分市场和地区细分（所有5 个我们调查详细区域市场趋势、近期主要业务联盟和资本交易动向（投资、併购等）、当前竞争状况以及主要公司概况。

主要细分市场

依提供的产品/设备类型

  • 肉毒桿菌毒素
  • 真皮填充剂
  • 化学换肤
  • 轮廓
  • 臀部植入物
  • 脱髮
  • 乳房植入物
  • 其他产品/设备

按治疗类型

  • 非侵入性
  • 微创
  • 侵入式

最终用户

  • 医院
  • 诊所/医疗水疗中心、皮肤/美容中心
  • 其他最终用户

按性别

  • 男性
  • 女士

按销售管道

  • 直销
  • 间接销售

按主要地区

  • 北美
  • 欧洲
  • 亚太地区
  • 中东/北非
  • 拉丁美洲

在这份报告中，

主要市场参与者

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

目录

第一章简介

第二章研究方法

第三章 经济趋势和其他项目特定考虑因素

第 4 章执行摘要

第 5 章 简介

  • 医学美容理念
  • 医美的演变
  • 医美的种类
  • 医美的好处
  • 医美副作用
  • 主要成长动力
  • 医疗美容最新技术
  • 医疗美容面临的主要挑战
  • 未来展望

第六章 市场状况

  • 医美企业：市场现状

第七章公司简介

  • 主要公司简介
  • 其他公司概况

第八章企业竞争力分析

  • 主要先决条件和参数
  • 调查方法
  • 医美：企业竞争力分析

第 9 章 伙伴关係与合作

  • 合作模式
  • 医学美学：伙伴关係与合作
  • 区域分析

第十章 融资与投资

  • 融资模式
  • 医疗美容：融资与投资
  • 结论

第11章 DELT分析

  • 调查方法
  • 主要参数
  • 医美：DELT分析
  • 结论

第十二章市场影响分析：促进因素、限制因素、机会与挑战

  • 市场驱动力
  • 市场製约因素
  • 市场机会
  • 市场挑战
  • 结论

第十三章 全球医美市场

  • 主要假设及研究方法
  • 全球医美市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 主要细分市场
  • 动态仪表板

第十四章医疗美容市场：依提供的产品/设备类型分类

  • 主要假设及研究方法
  • 医疗美容市场：依提供的产品/设备类型划分（2018、2023、2035）
  • 数据测量和验证

第十五章医疗美容市场：依治疗类型

  • 主要假设及研究方法
  • 医疗美容市场：依治疗类型划分（2018年、2023年、2035年）
  • 数据测量和验证

第十六章医疗美容市场：依最终用户分类

  • 主要假设及研究方法
  • 医疗美容市场：依最终用户划分（2018、2023、2035）
  • 数据测量和验证

第十七章 医疗美容市场：依性别分类

  • 主要假设及研究方法
  • 医疗美容市场：依性别划分（2018、2023、2035）
  • 数据测量和验证

第十八章医疗美容市场：依分销管道划分

  • 主要假设及研究方法
  • 医疗美容市场：依分销管道划分（2018、2023、2035）
  • 数据测量和验证

第十九章 医疗美容市场：依主要地区

  • 主要假设及研究方法
  • 医疗美容市场：依主要地区划分（2018、2023、2035）
  • 数据测量和验证

第二十章 医美产品市场

  • 主要假设及研究方法
  • 全球医疗美容产品市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 数据测量和验证

第21章管理见解

第22章结论

第23章附录1：表格数据

第二十四章 附录2：公司与组织名单

简介目录
Product Code: RA100467

The medical aesthetics market is valued at USD 35 billion in 2023 growing at a CAGR of 9.3% during the forecast period 2023-2035.

The growing demand for medical aesthetic solutions in recent years can be attributed to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID pandemic has also contributed significantly towards the increased number of annual aesthetic treatments. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing the cosmetic appearance of an individual without clinical surgery. These treatments are mainly used for anti-aging purposes by reducing fine lines and wrinkles, lifting flabby skin, and skin rejuvenation. Medical aesthetic procedures can also help in reducing excess fat and cellulite, unwanted hair, and spider veins. According to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive aesthetic procedures and 19 million non-invasive aesthetic procedures have been performed globally in 2022. It is worth mentioning that nearly 90% of the industry clientele are women, however, these aesthetic procedures are also gaining popularity among men. In fact, men have shown an increased interest in the majority of major surgical and nonsurgical procedures, with the top cosmetic surgical procedures for men being rhinoplasty, eyelid surgery, cheek implant, breast reduction, liposuction, tummy tuck, and ear surgery. The reasons behind the growth of the male aesthetic market tend to be the same as those that have led to the growth of the female aesthetic market, including the desire for natural-looking results, minimally invasive procedures, and increased awareness of appearance.

Due to the high demand for these procedures, medical aesthetics companies have developed medical aesthetics products & devices. The main focus of medical aesthetics companies is to develop non-surgical or minimally invasive solutions. The majority of these treatments don't require a full surgical procedure. This means less pain and discomfort, fewer risks, shorter hospital stays, and long-lasting results. Some of the most common minimally invasive treatments are Botulism toxins and aesthetic filler. These treatments are mainly used for improving glabellar lines and tightening the skin. However, the advantages of aesthetic treatments aren't only cosmetic. They also help in solving other common healthcare problems. Botulism toxin is used to control sweating and migraines. Body contouring devices, laser hair removal, tattoo removal, and nail treatments are some of the other common non-surgical treatments. Body contouring devices are used for tightening the skin, reducing fat, and reducing cellulite.

Medical aesthetics treatments can be performed at a medical aesthetic clinic or at a medical spa. Dermatologists, plastic surgeons, doctors, nurse practitioners, registered nurses and aestheticians are among the medical professionals who can provide medical aesthetics treatments. It is interesting to note that more than 70% of the present medical aesthetics market is managed by hospitals, clinics and medical spas. In addition, South Korea, the plastic surgery capital in the world, is the country with the highest cosmetic surgeries per capita. This is because of the well-established cosmetic surgery infrastructure and the skilled medical professionals who encourage aesthetics medical tourism to South Korea. The main concern is that some medical professionals and the medical aesthetics companies are violating the regulatory guidelines, which can lead to side-effects. Therefore, it is extremely important for the patient to undergo medical aesthetics treatment by a licensed medical professional, using certified aesthetic devices, to avoid any such risks and complications. By overcoming these obstacles and meeting the increasing demand for medical aesthetics services, medical aesthetics companies are projected to see tremendous growth in the coming years.

Key Market Segments

Type of Product and / or Device Offered

  • Botulinum Toxin
  • Dermal Fillers
  • Chemical Peels
  • Body Contouring
  • Gluteal Implants
  • Hair Removal
  • Breast Implants
  • Other Products / Devices

Type of Procedure

  • Non Invasive
  • Minimally Invasive
  • Invasive

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Gender

  • Male
  • Female

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

Research Coverage:

The report studies the medical aesthetics market based on type of product and / or device offered, type of procedure, end user, gender, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including its evolution, types, and application areas. It also covers the benefits of these procedures compared to traditional beauty treatments and the side effects associated with them. The chapter also covers the key drivers of growth, new technologies, key issues and future prospects in this field.

Comprehensive analysis of the current landscape of medical aesthetics developers considering parameters such as establishment year, company size, headquarters, type of offering (product and / or device), type of products and / or devices offered, application area, type of procedure and end user

In-depth profiles of companies offering medical aesthetic procedures products and / or devices, focusing on company overviews, financial information (where available), offered medical aesthetic procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of medical aesthetics company, considering supplier strength in terms of type of offering, type of product and / or device offered and type of procedure, and number of end users served.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the medical aesthetics market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Types of Medical Aesthetic Procedures
    • 5.4.1. Non-invasive Procedures
      • 5.4.1.1. Facial Aesthetics
        • 5.4.1.1.1. Botulinum Toxin
        • 5.4.1.1.2. Dermal Fillers
        • 5.4.1.1.3. Chemical Peels
        • 5.4.1.1.4. Microdermabrasion
        • 5.4.1.1.5. Microneedling
        • 5.4.1.1.6. Thread Lift
      • 5.4.1.2. Body Contouring
      • 5.4.1.3. Hair Removal
        • 5.4.1.3.1. Intense Pulse Light Hair Removal
        • 5.4.1.3.2. Laser Hair Removal
      • 5.4.1.4. Tattoo Removal
      • 5.4.1.5. Nail Treatment
      • 5.4.1.6. Eyelash Treatment
      • 5.4.1.7. Permanent Make-up
    • 5.4.2. Invasive Procedures
      • 5.4.2.1. Breast Surgery
      • 5.4.2.2. Gluteal Implants
      • 5.4.2.3. Facial Surgery
      • 5.4.2.4. Liposuction
      • 5.4.2.5. Cosmetic Gynecology
  • 5.5. Advantages of Medical Aesthetics
  • 5.6. Side Effects of Medical Aesthetics
  • 5.7. Key Growth Drivers
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Medical Aesthetic Companies: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Type of Offering
    • 6.2.8. Analysis by Type of Products and / or Devices Offered
    • 6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
    • 6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
    • 6.2.11. Analysis by Type of Hair Removal Devices Offered
    • 6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
    • 6.2.13. Analysis by Application Area
    • 6.2.14. Analysis by Type of Procedure
    • 6.2.15. Analysis by End-user
    • 6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
    • 6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Detailed Company Profiles of Key Players
    • 7.2.1. Companies Headquartered in North America
      • 7.2.1.1. Allergan Aesthetics
        • 7.2.1.1.1. Company Overview
        • 7.2.1.1.2. Financial Information
        • 7.2.1.1.3. Medical Aesthetics Portfolio
        • 7.2.1.1.4. Recent Developments and Future Outlook
      • 7.2.1.2. Candela Medical
        • 7.2.1.2.1. Company Overview
        • 7.2.1.2.2. Medical Aesthetics Portfolio
        • 7.2.1.2.3. Recent Developments and Future Outlook
      • 7.2.1.3. Cynosure
        • 7.2.1.3.1. Company Overview
        • 7.2.1.3.2. Medical Aesthetics Portfolio
        • 7.2.1.3.3. Recent Developments and Future Outlook
      • 7.2.1.4. Lutronic
        • 7.2.1.4.1. Company Overview
        • 7.2.1.4.2. Medical Aesthetics Portfolio
        • 7.2.1.4.3. Recent Developments and Future Outlook
      • 7.2.1.5. Mentor
        • 7.2.1.5.1. Company Overview
        • 7.2.1.5.2. Medical Aesthetics Portfolio
        • 7.2.1.5.3. Recent Developments and Future Outlook
    • 7.2.2. Companies Headquartered in Europe
      • 7.2.2.1. BTL Aesthetics
        • 7.2.2.1.1. Company Overview
        • 7.2.2.1.2. Medical Aesthetics Portfolio
        • 7.2.2.1.3. Recent Developments and Future Outlook
      • 7.2.2.2. Croma Pharma
        • 7.2.2.2.1. Company Overview
        • 7.2.2.2.2. Financial Information
        • 7.2.2.2.3. Medical Aesthetics Portfolio
        • 7.2.2.2.4. Recent Developments and Future Outlook
      • 7.2.2.3. Galderma
        • 7.2.2.3.1. Company Overview
        • 7.2.2.3.2. Financial Information
        • 7.2.2.3.3. Medical Aesthetics Portfolio
        • 7.2.2.3.4. Recent Developments and Future Outlook
      • 7.2.2.4. IBSA
        • 7.2.2.4.1. Company Overview
        • 7.2.2.4.2. Medical Aesthetics Portfolio
        • 7.2.2.4.3. Recent Developments and Future Outlook
      • 7.2.2.5. Sinclair Pharma
        • 7.2.2.5.1. Company Overview
        • 7.2.2.5.2. Medical Aesthetics Portfolio
        • 7.2.2.5.3. Recent Developments and Future Outlook
    • 7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
      • 7.2.3.1. Classys
        • 7.2.3.1.1. Company Overview
        • 7.2.3.1.2. Financial Information
        • 7.2.3.1.3. Medical Aesthetics Portfolio
        • 7.2.3.1.4. Recent Developments and Future Outlook
      • 7.2.3.2. Daeyang Medical
        • 7.2.3.2.1. Company Overview
        • 7.2.3.2.2. Medical Aesthetics Portfolio
        • 7.2.3.2.3. Recent Developments and Future Outlook
      • 7.2.3.3. Establishment Labs
        • 7.2.3.3.1. Company Overview
        • 7.2.3.3.2. Financial Information
        • 7.2.3.3.3. Medical Aesthetics Portfolio
        • 7.2.3.3.4. Recent Developments and Future Outlook
      • 7.2.3.4. Lumenis
        • 7.2.3.4.1. Company Overview
        • 7.2.3.4.2. Medical Aesthetics Portfolio
        • 7.2.3.4.3. Recent Developments and Future Outlook
      • 7.2.3.5. Shanghai Haohai Biological Technology
        • 7.2.3.5.1. Company Overview
        • 7.2.3.5.2. Financial Information
        • 7.2.3.5.3. Medical Aesthetics Portfolio
        • 7.2.3.5.4. Recent Developments and Future Outlook
  • 7.3. Short Profiles of Other Prominent Players
    • 7.3.1. ADSS
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Medical Aesthetics Portfolio
    • 7.3.2. Astiland
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Medical Aesthetics Portfolio
    • 7.3.3. Beijing Kes Biological Technology
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Medical Aesthetics Portfolio
    • 7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
      • 7.3.4.2. Medical Aesthetics Portfolio
    • 7.3.5. MedicalZone
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Medical Aesthetics Portfolio
    • 7.3.6. Sanhe Medical
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Medical Aesthetics Portfolio
    • 7.3.7. Sincoheren
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Medical Aesthetics Portfolio
    • 7.3.8. Skin Tech Pharma
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Medical Aesthetics Portfolio
    • 7.3.9. Wontech
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Medical Aesthetics Portfolio
    • 7.3.10. Zesay Beauty
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Medical Aesthetics Portfolio

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Medical Aesthetics: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Medical Aesthetics: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.8. Leading Investors: Analysis by Number of Funding Instances
    • 10.3.9. Analysis by Company Size and Amount Invested
  • 10.4. Concluding Remarks

11. DELT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Methodology
  • 11.3. Key Parameters
    • 11.3.1. Demographical Factors
    • 11.3.2. Environmental Factors
    • 11.3.3. Legal Factors
    • 11.3.4. Technological Factors
  • 11.4. Medical Aesthetics: DELT Analysis
    • 11.4.1. Allergan Aesthetics
    • 11.4.2. Candela
    • 11.4.3. Cutera
    • 11.4.4. Biotechitalia
    • 11.4.5. Sinclair Pharma
    • 11.4.6. Merz Pharma
    • 11.4.7. Dermosistemi
    • 11.4.8. Alma Lasers
    • 11.4.9. Bison Medical
  • 11.5. Conclusion

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 12.1. Chapter Overview
  • 12.2. Market Drivers
  • 12.3. Market Restraints
  • 12.4. Market Opportunities
  • 12.5. Market Challenges
  • 12.6. Conclusion

13. GLOBAL MEDICAL AESTHETICS MARKET

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.1. Scenario Analysis
      • 13.3.1.1. Conservative Scenario Analysis
      • 13.3.1.2. Optimistic Scenario Analysis
  • 13.4. Key Market Segmentations
  • 13.5. Dynamic Dashboards

14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
    • 14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
    • 15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. MEDICAL AESTHETICS MARKET, BY END-USER

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
    • 16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. MEDICAL AESTHETICS MARKET, BY GENDER

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
    • 17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Data Triangulation and Validation

18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
    • 18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Data Triangulation and Validation

19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
    • 19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Data Triangulation and Validation

20. MEDICAL AESTHETICS PRODUCTS MARKET

  • 20.1. Chapter Overview
  • 20.2. Key Assumptions and Methodology
  • 20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
      • 20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
      • 20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.5. Data Triangulation and Validation

21. EXECUTIVE INSIGHTS

22. CONCLUSION

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS